Zymergen, a leading provider of artificial intelligence (AI) and machine learning (ML) solutions, has recently announced the acquisition of Trials.ai, an AI-powered clinical trial...
Verastem Oncology is a biopharmaceutical company that is focused on the development of treatments for cancer. The company is currently developing avutometinib, a novel...
Idiopathic pulmonary fibrosis (IPF) is a debilitating lung disease that affects millions of people around the world. It is characterized by the formation of...
Exscientia, a leading artificial intelligence (AI) drug discovery company, and Bristol Myers Squibb (BMS), a global biopharmaceutical company, have announced the launch of the...
In a recent development, Guardant Health and AnHeart Therapeutics have announced a strategic partnership to develop diagnostic tests for advanced or metastatic ROS1-positive non-small...
Looks like you are using an ad-blocking browser extension. We request you to whitelist our website on the ad-blocking extension and refresh your browser to view the content.
